Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...

The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...

Detroit patients getting HEMGENIX report life‑changing results; trial data show 94% off prophylaxis at five years.

Investigating a common gene in three very different species—salamanders, mice and zebrafish—scientists have discovered the ...

After its bet on a rare eye disease gene therapy ended in a phase 3 fail last year, Johnson & Johnson is now returning the ...

Andhra Pradesh Minister Nara Lokesh on Saturday oversaw the administration of a Rs 16-crore injection, Zolgensma, to a baby girl in Kurnool district, with part of the cost reportedly bridged through ...

The treatment for primary immunodeficient diseases is varied. As mentioned before, the most common type of primary immunodeficient disease are antibody deficiencies. Either patients don't make enough ...

As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial ...

Pfizer announced in February 2025 that it was taking Beqvez (fidanacogene elaparvovec), its gene therapy for hemophilia B, ...

VIJAYAWADA: In a major humanitarian gesture, HRD and IT Minister Nara Lokesh played a crucial role in saving one-year-old ...